Effect of Noni Juice on Lipid Peroxidation-derived DNA Adducts in Heavy Smokers
Completed · Phase 2 · Has a placebo group
Conditions studied: DNA Damage
In brief
The purpose of this study was to determine if noni juice reduces lipid hydroperoxide (LOOH) and malondialdehyde (MDA) derived-DNA adducts, markers of oxidative DNA damage, in peripheral blood lymphocytes of cigarette smokers.
Key facts
- Study ID
- NCT01677169
- Run by
- Tahitian Noni International, Inc.
- People needed
- 317
- Starts
- 2000-09-01
- Expected to finish
- 2006-08-01
- Last updated by the study team
- 2019-09-11
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- 18 to 65 years in age, smoker of more than 20 cigarettes per day, a smoking history exceeding one year, and willing to complete a one month trial.
You may not qualify if…
- concurrent use, or use in the previous three months, of prescription medication or antioxidant vitamins
Where it is running
- University of Illinois College of Medicine at Rockford — Rockford, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.